QQQ   310.43 (+0.22%)
AAPL   159.97 (+0.65%)
MSFT   279.93 (+0.82%)
META   206.05 (+0.87%)
GOOGL   105.33 (-0.26%)
AMZN   97.93 (-0.79%)
TSLA   189.85 (-1.23%)
NVDA   267.32 (-1.69%)
NIO   9.06 (-2.27%)
BABA   86.70 (+0.21%)
AMD   97.87 (-2.40%)
T   18.61 (+0.81%)
F   11.49 (+0.61%)
MU   60.96 (-0.62%)
CGC   1.91 (-0.26%)
GE   91.07 (-0.57%)
DIS   94.01 (-1.90%)
AMC   4.43 (-0.89%)
PFE   40.31 (+0.32%)
PYPL   73.68 (+1.54%)
NFLX   328.22 (+2.45%)
QQQ   310.43 (+0.22%)
AAPL   159.97 (+0.65%)
MSFT   279.93 (+0.82%)
META   206.05 (+0.87%)
GOOGL   105.33 (-0.26%)
AMZN   97.93 (-0.79%)
TSLA   189.85 (-1.23%)
NVDA   267.32 (-1.69%)
NIO   9.06 (-2.27%)
BABA   86.70 (+0.21%)
AMD   97.87 (-2.40%)
T   18.61 (+0.81%)
F   11.49 (+0.61%)
MU   60.96 (-0.62%)
CGC   1.91 (-0.26%)
GE   91.07 (-0.57%)
DIS   94.01 (-1.90%)
AMC   4.43 (-0.89%)
PFE   40.31 (+0.32%)
PYPL   73.68 (+1.54%)
NFLX   328.22 (+2.45%)
QQQ   310.43 (+0.22%)
AAPL   159.97 (+0.65%)
MSFT   279.93 (+0.82%)
META   206.05 (+0.87%)
GOOGL   105.33 (-0.26%)
AMZN   97.93 (-0.79%)
TSLA   189.85 (-1.23%)
NVDA   267.32 (-1.69%)
NIO   9.06 (-2.27%)
BABA   86.70 (+0.21%)
AMD   97.87 (-2.40%)
T   18.61 (+0.81%)
F   11.49 (+0.61%)
MU   60.96 (-0.62%)
CGC   1.91 (-0.26%)
GE   91.07 (-0.57%)
DIS   94.01 (-1.90%)
AMC   4.43 (-0.89%)
PFE   40.31 (+0.32%)
PYPL   73.68 (+1.54%)
NFLX   328.22 (+2.45%)
QQQ   310.43 (+0.22%)
AAPL   159.97 (+0.65%)
MSFT   279.93 (+0.82%)
META   206.05 (+0.87%)
GOOGL   105.33 (-0.26%)
AMZN   97.93 (-0.79%)
TSLA   189.85 (-1.23%)
NVDA   267.32 (-1.69%)
NIO   9.06 (-2.27%)
BABA   86.70 (+0.21%)
AMD   97.87 (-2.40%)
T   18.61 (+0.81%)
F   11.49 (+0.61%)
MU   60.96 (-0.62%)
CGC   1.91 (-0.26%)
GE   91.07 (-0.57%)
DIS   94.01 (-1.90%)
AMC   4.43 (-0.89%)
PFE   40.31 (+0.32%)
PYPL   73.68 (+1.54%)
NFLX   328.22 (+2.45%)
NASDAQ:MNOV

MediciNova - MNOV Stock Forecast, Price & News

$2.21
+0.01 (+0.45%)
(As of 03/24/2023 02:14 PM ET)
Add
Compare
Today's Range
$2.17
$2.25
50-Day Range
$1.95
$2.52
52-Week Range
$1.89
$3.18
Volume
4,161 shs
Average Volume
27,787 shs
Market Capitalization
$108.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

MediciNova MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.08mentions of MediciNova in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.30) to ($0.34) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.92 out of 5 stars

Medical Sector

984th out of 989 stocks

Pharmaceutical Preparations Industry

477th out of 480 stocks


MNOV stock logo

About MediciNova (NASDAQ:MNOV) Stock

MediciNova, Inc. is a biopharmaceutical company, which engages in the acquisition and development of small molecule therapeutics for the treatment of diseases with unmet medical needs. Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers. The company was founded by Yuichi Iwaki on September 26, 2000 and is headquartered in La Jolla, CA.

Receive MNOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter.

MNOV Stock News Headlines

MediciNova (NASDAQ:MNOV) Now Covered by StockNews.com
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
See More Headlines
Receive MNOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediciNova and its competitors with MarketBeat's FREE daily newsletter.

MNOV Company Calendar

Last Earnings
10/26/2020
Today
3/24/2023
Next Earnings (Estimated)
3/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MNOV
Employees
11
Year Founded
2000

Profitability

Net Income
$-14,060,000.00
Pretax Margin
-2,628,577.25%

Debt

Sales & Book Value

Annual Sales
$4.04 million
Book Value
$1.43 per share

Miscellaneous

Free Float
40,855,000
Market Cap
$107.42 million
Optionable
Optionable
Beta
0.98

Social Links


Key Executives

  • Yuichi Iwaki
    President, Chief Executive Officer & Director
  • Jason Kruger
    Chief Financial Officer
  • Kazuko Matsuda
    Director & Chief Medical Officer
  • Geoffrey G. O'Brien
    Vice President & Executive Officer
  • David H. Crean
    Chief Business Officer













MNOV Stock - Frequently Asked Questions

Should I buy or sell MediciNova stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for MediciNova in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" MNOV shares.
View MNOV analyst ratings
or view top-rated stocks.

How have MNOV shares performed in 2023?

MediciNova's stock was trading at $2.05 at the beginning of 2023. Since then, MNOV shares have increased by 6.8% and is now trading at $2.19.
View the best growth stocks for 2023 here
.

When is MediciNova's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our MNOV earnings forecast
.

How were MediciNova's earnings last quarter?

MediciNova, Inc. (NASDAQ:MNOV) announced its earnings results on Monday, October, 26th. The biopharmaceutical company reported ($0.08) earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.04.

What other stocks do shareholders of MediciNova own?
What is MediciNova's stock symbol?

MediciNova trades on the NASDAQ under the ticker symbol "MNOV."

Who are MediciNova's major shareholders?

MediciNova's stock is owned by a variety of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (0.89%), Jane Street Group LLC (0.55%), Millennium Management LLC (0.51%), JPMorgan Chase & Co. (0.51%), HRT Financial LP (0.37%) and Bank of America Corp DE (0.36%).
View institutional ownership trends
.

How do I buy shares of MediciNova?

Shares of MNOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MediciNova's stock price today?

One share of MNOV stock can currently be purchased for approximately $2.19.

How much money does MediciNova make?

MediciNova (NASDAQ:MNOV) has a market capitalization of $107.42 million and generates $4.04 million in revenue each year.

How can I contact MediciNova?

MediciNova's mailing address is 4275 EXECUTIVE SQUARE SUITE 300, LA JOLLA CA, 92037. The official website for the company is medicinova.com. The biopharmaceutical company can be reached via phone at (858) 373-1500, via email at info@medicinova.com, or via fax at 858-404-0048.

This page (NASDAQ:MNOV) was last updated on 3/24/2023 by MarketBeat.com Staff